AIP
VSTM icon

Arrowpoint Investment Partners’s Verastem VSTM Stock Holding History

Arrowpoint Investment Partners’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,170
Closed -$192K – 166
2026
Q1 		$192K Buy
+36,170
New +$223K 0.17% 71
2025
Q4 		– Sell
-29,087
Closed -$257K – 148
2025
Q3 		$257K Buy
+29,087
New +$216K 0.26% 59

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arrowpoint Investment Partners's VSTM Position: Q2 2026 in Review

Arrowpoint Investment Partners sold out of Verastem (VSTM) in Q2 2026, closing a stake of 36,170 shares — an estimated $192K sold.

Arrowpoint Investment Partners first reported a position in VSTM in Q3 2025 and held it in 2 quarters. The position peaked at $257K in Q3 2025. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Arrowpoint Investment Partners reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 36,170 Verastem shares in Q2 2026, an estimated $192K.
  • Arrowpoint Investment Partners first reported a position in Verastem in Q3 2025 and held it in 2 quarters.
  • Arrowpoint Investment Partners's Verastem position peaked at $257K in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.